Vineet Laboratories Share Price

Vineet Laboratories Limited is an India-based company engaged in the business of drug intermediates and bulk drugs. The Company specializes in pharmaceutical intermediates and fine chemicals. Its active pharmaceutical ingredient (API) intermediates products include Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, and Piroctone Olanine. Its fine chemicals and reagents include Isopropyl-beta-D-thiogalactopyranoside, 4-Nitrophenyl phosphate disodium salt, 5-Bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-Gal), 5-Acetyl thiophene-2-carboxilic acid, n-Butyl Lithium, n-Butyl magnesium chloride, 3-Furaldehyde, 3-bromofuran, 1-methyl-imidazole-2-carboxaldehyde, 6-Aminouracil, Ethyldiazo acetate, and Phenylboronic acid. The Company also exports API intermediates, fine chemicals, and custom synthesis molecules.As of 26 May 2026, Vineet Laboratories share price is ₹35.00. The stock opened at ₹35.25, compared to its previous close of ₹35.60. During today's trading session, Vineet Laboratories share price moved in the range of ₹34.55 to ₹35.99, with an average price of ₹35.27 for the day. Looking at its last 52-week, the stock has touched a low of ₹34.55 and a high of ₹35.99. On the performance front, Vineet Laboratories share price has declined by 17.62% over the last six months and is up 10.07% on a year-on-year basis.

The market capitalization of Vineet Laboratories is ₹68 Crs, with a P/E ratio of -7.0 and a dividend yield of 0.00%.